These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2114114)

  • 1. Biochemical characterization of amyloid derived from the variable region of the kappa light chain subgroup III.
    Picken MM; Gallo GR; Pruzanski W; Frangione B
    Arthritis Rheum; 1990 Jun; 33(6):880-4. PubMed ID: 2114114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Light chain deposition disease derived from the kappa I light chain subgroup. Biochemical characterization.
    Picken MM; Frangione B; Barlogie B; Luna M; Gallo G
    Am J Pathol; 1989 Apr; 134(4):749-54. PubMed ID: 2495723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deposition of kappa and lambda light chains in amyloid filaments of dialysis-related amyloidosis.
    Brancaccio D; Ghiggeri GM; Braidotti P; Garberi A; Gallieni M; Bellotti V; Zoni U; Gusmano R; Coggi G
    J Am Soc Nephrol; 1995 Oct; 6(4):1262-70. PubMed ID: 8589295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural evidence for colocalization of kappa light chain- and beta 2-microglobulin-derived amyloids using double labelling immunogold electron microscopy.
    Takahashi M; Hoshii Y; Kawano H; Gondo T; Ishihara T; Isobe T
    Virchows Arch; 1996 Dec; 429(6):383-8. PubMed ID: 8982384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic mutations of the L12a gene in V-kappa(1) light chain deposition disease: potential effects on aberrant protein conformation and deposition.
    Vidal R; Goñi F; Stevens F; Aucouturier P; Kumar A; Frangione B; Ghiso J; Gallo G
    Am J Pathol; 1999 Dec; 155(6):2009-17. PubMed ID: 10595931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumoral non-amyloidotic monoclonal immunoglobulin light chain deposits ('aggregoma'): presenting feature of B-cell dyscrasia in three cases with immunohistochemical and biochemical analyses.
    Rostagno A; Frizzera G; Ylagan L; Kumar A; Ghiso J; Gallo G
    Br J Haematol; 2002 Oct; 119(1):62-9. PubMed ID: 12358904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic detection of immunoglobulin light chain variable region peptides from amyloidosis patient biopsies.
    Dasari S; Theis JD; Vrana JA; Meureta OM; Quint PS; Muppa P; Zenka RM; Tschumper RC; Jelinek DF; Davila JI; Sarangi V; Kurtin PJ; Dogan A
    J Proteome Res; 2015 Apr; 14(4):1957-67. PubMed ID: 25734799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended analysis of AL-amyloid protein from abdominal wall subcutaneous fat biopsy: kappa IV immunoglobulin light chain.
    Olsen KE; Sletten K; Westermark P
    Biochem Biophys Res Commun; 1998 Apr; 245(3):713-6. PubMed ID: 9588180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin allotypes are not involved in systemic amyloidosis.
    Ockhuizen T; Westra H; Bijzet J; Post J; van Leeuwen M; van Rijswijk M
    J Rheumatol; 1985 Aug; 12(4):742-6. PubMed ID: 3932652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of immunoglobulin light chain amyloidosis with antibodies to the immunoglobulin light chain variable region.
    Hoshii Y; Kiyama M; Cui D; Kawano H; Ishihara T
    Pathol Int; 2006 Jun; 56(6):324-30. PubMed ID: 16704496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light-chain amyloid proteins.
    Stevens PW; Raffen R; Hanson DK; Deng YL; Berrios-Hammond M; Westholm FA; Murphy C; Eulitz M; Wetzel R; Solomon A
    Protein Sci; 1995 Mar; 4(3):421-32. PubMed ID: 7795526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis.
    Clos AL; Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Jackson GR; Kelly B; Beachkofsky TM; Kayed R
    Br J Dermatol; 2011 Dec; 165(6):1349-54. PubMed ID: 21729025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain.
    Davis DP; Gallo G; Vogen SM; Dul JL; Sciarretta KL; Kumar A; Raffen R; Stevens FJ; Argon Y
    J Mol Biol; 2001 Nov; 313(5):1021-34. PubMed ID: 11700059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-lambda-light chain-peptide antibodies are suitable for the immunohistochemical classification of AL amyloid.
    Kuçi H; Ebert MP; Röcken C
    Histol Histopathol; 2007 Apr; 22(4):379-87. PubMed ID: 17290348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient.
    Stokes MB; Jagirdar J; Burchstin O; Kornacki S; Kumar A; Gallo G
    Mod Pathol; 1997 Oct; 10(10):1059-65. PubMed ID: 9346188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AH amyloidosis associated with an immunoglobulin heavy chain variable region (VH1) fragment: a case report.
    Miyazaki D; Yazaki M; Gono T; Kametani F; Tsuchiya A; Matsuda M; Takenaka Y; Hosh Y; Ikeda S
    Amyloid; 2008 Jun; 15(2):125-8. PubMed ID: 18484339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nodular glomerulopathy associated with nonamyloidotic kappa light chain deposits and excess immunoglobulin light chain synthesis.
    Gallo GR; Feiner HD; Katz LA; Feldman GM; Correa EB; Chuba JV; Buxbaum JN
    Am J Pathol; 1980 Jun; 99(3):621-44. PubMed ID: 6770693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary local orbital amyloidosis: biochemical identification of the immunoglobulin light chain kappaIII subtype in a small formalin fixed, paraffin wax embedded tissue sample.
    Kaplan B; Martin BM; Cohen HI; Manaster J; Kassif Y; Rehany U; Livneh A
    J Clin Pathol; 2005 May; 58(5):539-42. PubMed ID: 15858128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino-terminal identity of co-existent amyloid and non-amyloid immunoglobulin kappa light chain deposits. A human disease to study alterations of protein conformation.
    Kaplan B; Vidal R; Kumar A; Ghiso J; Frangione B; Gallo G
    Clin Exp Immunol; 1997 Dec; 110(3):472-8. PubMed ID: 9409653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat-induced native dimerization prevents amyloid formation by variable domain from immunoglobulin light-chain REI.
    Nawata M; Tsutsumi H; Kobayashi Y; Unzai S; Mine S; Nakamura T; Uegaki K; Kamikubo H; Kataoka M; Hamada D
    FEBS J; 2017 Sep; 284(18):3114-3127. PubMed ID: 28736891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.